Mastering Power BI for Data Analytics & Storytelling
About this Specialization
Our Power BI specialization is suitable for individuals who are new to the field, as well as business analysts, database administrators, BI developers, IT professionals, data analysts, data engineers, and data scientists who are seeking to enhance their abilities in designing databases, managing and transforming data, utilizing DAX, creating reports and publishing dashboards, generating and observing AI insights, machine learning, analytic applications, analyzing AI-generated reports, and managing data sources through our carefully curated 5 courses.\\n\\nYou will be able to preprocess data, analyze data, create reports and dashboards, and perform AI analytics with image and text data. This specialization will provide you with the comprehensive skill set necessary for data management and visualization. Elevate your knowledge with our specialized Power BI program, a transformative learning experience designed to provide you with the necessary skills for efficient data management and effective visualization.Created by: Edureka

Related Online Courses
This course is designed for a beginner software developer who wants to gain a comprehensive understanding of Docker and Containerization. Some software development experience is recommended, but no... more
This six course specialization is designed to prepare you to take the certification examination for IBM AI Enterprise Workflow V1 Data Science Specialist. IBM AI Enterprise Workflow is a... more
This course offers a comprehensive exploration into advanced API development using Node.js, Express, and MongoDB, all within the context of building a fully functional Twitter Clone. Starting with... more
Algorithms are the heart of computer science, and the subject has countless practical applications as well as intellectual depth. This specialization is an introduction to algorithms for learners... more
Kidney transplantation is a major advance of modern medicine which provides high-quality of life for patients with end-stage renal disease. What used to be an experimental, risky, and very limited... more